Login
Toggle navigation
Videos
Categories
Trending
How to Break Into Venture Capital (VC)|Lindy Morris Fishburne,Managing Partner,Breakout Ventures
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Invests at the intersection of technology and biology.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Timmins Mayor George Pirie Launches Mining Projects Pipeline at Abitibi Virtual Event | Elisabeth Spatz DiVeto - President of New Brunswick Prospectors & Developers Association
00:10:00
Ensuring an Equitable Energy Transition | Alexander Morrison - Founder of Morrison Foerster
00:10:00
Jeffries' Profit Drop Signals Potential Sector-Wide Challenges
00:10:00
The worlds largest portfolio of marketplace startups|Fabrice Grinda,Founding Partner,FJ Labs
00:10:00
Inside the Mind of Emmanuel Roman: PIMCO's Visionary Leader on Fixed Income, AI, and Market Opportunities| Emmanuel Roman, CEO, PIMCO.
00:10:00
Pioneering prediction and prevention in dermatology|Pia Renaudin, CEO,SciBase Holdings
00:10:00
Telling founders no Board meeting etiquette|Michael Luciani,Managing Partner,Climate Capital
00:10:00
Navigating Investment Opportunities: Insights from DWS CIO Björn Jesch
00:10:00
Sun4Energy: CEO Klas Zetterman on New Growth Post-Merger with Niutech | Klas Zetterman, CEO , Sun4Energy Group AB.
00:10:00
How Kotak Mahindra Bank Turned ₹1 Lakh into ₹2,000 Crores: A Success Story
00:10:00
BlackLine's Founder Therese Tucker Reflects on 20 Years as CEO | Therese Tucker, CEO, BlackLine Inc.
00:10:00
Seeing the potential in Box CEO Aaron Levie|Mamoon Hamid,Partner, Kleiner Perkins